Phagocytic degradation of chylomicron remnants by fibroblasts from subjects with homozygous familial hypercholesterolaemia

Clinical Science

Volumn 92, Issue 2, 1997, Pages 197-203

  Kenneth, C W Yu ^a   Smith, Darrin ^a   Yamamoto, Akira ^b   Kawaguchi, Akito ^b   Harada Shiba, Mariko ^b   Yamamura, Taku ^b   Mamo, John C L ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Atherosclerosis; Chylomicron remnants; Hypercholesterolaemia; Phagocytosis

Indexed keywords

ALPHA 2 MACROGLOBULIN; CELL SURFACE PROTEIN; CHYLOMICRON; CYTOCHALASIN D; LACTOFERRIN; LIPOPROTEIN; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; POLYINOSINIC ACID;

ADULT; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FIBROBLAST; HUMAN; HUMAN CELL; LIPID STORAGE; LIPOPROTEIN METABOLISM; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN TRANSPORT; RECEPTOR BINDING;

EID: 8044229406     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0920197     Document Type: Article

References (24)

1. Goldstein JL, Brown MS. The LDL receptor defect in familial hypercholesterolemia: implication for pathogenesis and therapy. Med Clin North Am 1982; 66: 335-62.
2. Redgrave TG. Formation and metabolism of chylomicrons. Int Rev Physiol 1983; 28: 103-30.
3. Rubinsztein DC, Cohen JC, Berger M, van der Westhuyzen DR, Coetzee GA, Gevers W. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects. J Clin Invest 1990; 86: 1306-12.
4. Mamo JCL. Atherosclerosis as a postprandial disease. Endocrinol Metab 1995; 2: 229-44.
5. Castro-Cabezas M, Erkelens DW, Kock LAW, de Bruin TWA. Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides. Eur J Clin Invest 1994; 24: 669-78.
6. Kita T, Goldstein JL, Brown MS, Watanabe Y, Hornick CA, Havel RJ. Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor. Proc Natl Acad Sci USA 1982; 79: 3623-7.
7. Bowler A, Redgrave TG, Mamo JCL. Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor. Biochem J 1991; 276: 381-6.
8. Hussain MM, Innerarity TL, Brecht BJ, Mahley RW. Chylomicron metabolism in normal, cholesterol-fed and Watanabe Heritable Hyperlipidemic rabbits. Saturation of the sequestration step of the remnant clearance pathway. J Biol Chem 1995; 270: 8578-87.
9. Ishibashi S, Herz J, Maeda N, Goldstein JL, Brown MS. The two receptor model of lipoprotein clearance: test of the hypothesis in knockout mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci USA 1994; 91: 4431-5.
10. Choi SY, Fong LG, Kirven MJ, Cooper AD. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo. J Clin Invest 1991; 88: 1171-81.
11. Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK. The LDL receptor related protein, LRP, is an apolipoprotein E binding protein. Nature (London) 1989; 14: 162-4.
12. Beisiegel U, Weber W, Bengtsson-Olivercrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci USA 1991; 88: 8342-6.
13. Willnow TE, Sheng Z, Ishibashi S, Herz J. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science (Washington DC) 1994; 264: 1471-4.
14. 2-macroglobulin receptor. J Biol Chem 1991: 286: 13936-40.
15. Windler E, Greeve J, Levkau B, Kolb-Bachofen V, Daerr W, Greten H. The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants. Biochem J 1991; 276: 79-87.
16. Yen FT, Mann CJ, Guermani LM, et al. Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein. Biochemistry 1994; 33: 1172-80.
17. Mamo JCL, Elsegood CL, Gennat HC, Yu K. Degradation of chylomicron remnants by macrophages occurs via phagocytosis. Biochemistry 1996; 35: 10210-14.
18. Redgrave TG, Roberts DCK, West CE. Separation of lipoproteins by density gradient ultracentrifugation. Anal Biochem 1975; 65: 42-9.
19. Mamo JCL, Wheeler JR. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as smaller macromolecules including low density lipoprotein, high density lipoprotein and albumin. Coron Artery Dis 1994; 5: 695-705.
20. Funahashi T, Miyake Y, Yamamoto A, Matsuzawa YM, Kishino B-I. Mutations of the low density lipoprotein receptor in Japanese kindreds with familial hypercholesterolemia. Hum Genet 1988; 79: 103-8.
21. Pitas RE. Expression of the acetyl low density lipoprotein receptor by rabbit fibroblasts and smooth muscle cells. J Biol Chem 1990; 265: 12722-7.
22. 2-macroglobulin. J Biol Chem 1992; 267: 18551-7.
23. Krieger M, Herz, J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Ann Rev Biochem 1994; 63: 601-37.
24. Roitt I, Brostoff J, Male D. Immunology. 3rd edn. London: Mosby, 1993: 12.2-12.3.